ПОВОЛЖСКИЙ ОНКОЛОГИЧЕСКИЙ ВЕСТНИК 1 ( 28 )’ 2017
Loop // Protein Sci . — 2016 . — 25 ( 2 ). — P . 499-510 .
19 . Schuliga M . The inflammatory actions of coagulant and fibrinolytic proteases in disease // Mediators Inflamm . — 2015 . — P . 4376-95 .
20 . Shoji F ., Yano T ., Yoshino I ., et al . The dynamics and clinical significance of alpha 2 plasmin inhibitor-plasmin complex and thrombin-antithrombin complex in postoperative pleural effusion following a pulmonary lobectomy // Surg . Today . — 2009 . — 39 ( 4 ). — P . 320-5 . PMID : 19319640 DOI : 10.1007 / s00595-008-3865-9
21 . Suh Y . S ., Yu J ., Kim B . C ., et al . Overexpression of Plasminogen Activator Inhibitor-1 in Advanced Gastric Cancer with Aggressive Lymph Node Metastasis // Cancer Res . Treat . — 2015 . — 47 ( 4 ). — P . 718-26 . DOI : 10.4143 / crt . 2014.064
22 . Tang L ., Han X . The urokinase plasminogen activator system in breast cancer invasion and metastasis // Biomedicine and Pharmacotherapy . — 2013 . — 67 ( 2 ). — P . 179-182 . PMID : 23201006 DOI : 10.1016 / j . biopha . 2012.10.003
23 . Thomson C . A ., Crane T . E ., Miller A ., et al . A randomized trial of diet and physical activity in women treated for stage II-IV ovarian cancer : Rationale and design of the Lifestyle Intervention for Ovarian Cancer Enhanced
Survival ( LIVES ): An NRG Oncology / Gynecologic Oncology Group ( GOG-225 ) Study . Contemp . Clin . Trials . 2016 , Jul 6 ; pii : S . 1551-7144 ( 16 ): 30105-7 . [ Epub ahead of print ] PMID : 27394382 DOI : 10.1016 / j . cct . 2016.07.005
24 . Wang C . Y ., Chen C . L ., Tseng Y . L ., et al . Annexin A2 silencing induces G2 arrest of non-small cell lung cancer cells through p53-dependent and -independent mechanisms // J . Biol . Chem . — 2012 . — 287 . — P . 32512-24 . doi : 10.1074 / jbc . M112.351957 . [ PMC free article ] [ PubMed ] [ Cross Ref ]
25 . Witzel I ., Milde-Langosch K ., Schmidt M ., et al . Role of urokinase plasminogen activator and plasminogen activator inhibitor mRNA expression as prognostic factors in molecular subtypes of breast cancer // Onco . Targets Ther . — 2014 . Nov . 28 . — 7 . — P . 2205-13 . DOI : 10.2147 / OTT . S65344 . eCollection 2014 .
26 . Yamashita D ., Kondo T ., Ohue S ., et al . miR340 suppresses the stem-like cell function of gliomainitiating cells by targeting tissue plasminogen activator // Cancer Res . — 2015 . — 75 ( 6 ). — P . 1123-33 .
48 Клинические исследования и опыт в онкологии